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Experimental systems in which antigens elicit different responses among genetically 
distinct strains of mice have provided excellent tools for the study of mechanisms which 
govern specific immune responses. The characterization of some humoral responses has 
been facilitated through the analysis of their clonal composition by anti-idiotypic sera, 
isoelectric focusing, and the delineation of fine specificities for closely related antigens. 
With respect  to these  criteria,  interstrain  differences  have  now been  established  for 
murine responses to several antigens; including dextran (1, 2), p-azophenylarsonate (3, 
4),  streptococcal  group  A  carbohydrate  (5,  6),  (4-hydroxy-3-nitrophenyl) acetyl,(4-hy- 
droxy-5-bromo-3-nitrophenyl) acetyl (7, 8), staphylococcal ribonuclease (9), and phospho- 
rylcholine (PC) 1 (10, 11). In many of these studies, the expression of a particular defined 
specificity in serum antibodies has correlated closely with the presence of a given heavy- 
chain  allotypic  (CH) marker  (12). These  findings  have  been  interpreted  by  some 
investigators as a reflection of linkage of CH and variable region (VH) structural genes. 
As stated by these investigators, however, a fundamental and still unresolved interpre- 
tive  difficulty  exists  in  such  examinations:  Is  the  apparent  linkage  of CH  and  VH 
determinants  indicated  by serum  antibody studies  actually a  result  of VH  structural 
gene  differences,  or  may  some  of these  allotype-linked  expressions  reflect  instead, 
regulatory phenomena which act during or before antigenic stimulation? 
This interpretive difficulty stems in part from the ambiguity inherent in the exami- 
nation of heterogeneous serum antibody populations. In most serum antibody analyses, 
the designation of a  strain as positive or negative for a given clonotype rests upon the 
degree  of reactivity  observed  with  an  anti-idiotypic  serum.  Close  scrutiny  of such 
systems reveals that interstrain distinctions are rarely absolute. Rather, various degrees 
of cross-reactivity are observed.  In a  heterogeneous antibody mixture,  idiotypic cross- 
reactivity may indicate either a  diverse population of weakly cross-reactive antibodies 
or comparatively small  quantities  of the  homologous idiotype.  The  resolution  of this 
problem  can  only  be  accomplished  through  examination  of homogeneous  antibody 
populations. These may be obtained through either the fractionation of serum antibody 
components (13) or through the generation of monoclonal antibodies in vitro at limiting 
dilutions of precursor B cells (14). The latter method allows an enumeration of B cells of 
the  relevant  clonotype  and  thus  enables  the  quantitative  comparison  of precursor 
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population magnitude to serum expression. This type of comparison should allow a more 
definitive assessment  of the  clonotypes available  to  contribute to  the  net  reactivity 
observed in serum antibody analyses, and it should provide insight with respect to the 
regulatory mechanisms which might act between the precursor cell and serum levels of 
clonotype expression. 
Several aspects of the murine response to PC suggest an interplay of factors in the 
control of idiotype expression. The serum response of BALB/c and other strains of mice 
which bear the a 1 allotype is dominated by a clonotype identical to the TEPC 15 (T15) 
plasmacytoma  protein  (10). Strains  which  bear other  allotypes,  however,  vary with 
respect to the expression of T15. Sera from A/J mice (a  ~) display no anti-PC antibodies 
which are  identical to T15  by serological criteria.  C57BL/6  and other mice of the a 2 
allotype, however, display a  low level of cross-reactivity with T15 in both normal and 
immune sera (10). 
Recently, the anti-PC response of several murine strains has been examined at the 
individual precursor cell level (15-18).  The findings indicate that the majority of PC- 
responsive B cells in BALB/c mice are of the T15 clonotype. Further, strain AKR mice 
contain a minority of B cells which produce anti-PC antibodies indistinguishable from 
T15. C3H and A/J mice, however, display no clones whose products are identical to T15. 
Thus,  the  expression  of the  T15  clonotype at  the  precursor  cell  level  is  variable. 
Precursor cells of this clonotype can occur in allotypically distinct strains, although the 
degree of expression of this clonotype at the serum level appears to be closely associated 
with the Ig heavy-chain allotype markers. These findings suggest that the expression of 
a given clonotype may be regulated at several levels. 
In  the  present  study,  we  have  examined  several  parameters  which  may 
reflect various levels of the regulation of clonotype expression. Both the serum 
and monoclonal anti-PC response of BALB/c mice, which express high levels of 
serum T15; and those of C57BL/6 mice, which express low levels of serum T15; 
as well as congenic and recombinant inbred  (RI) strains  from these parental 
types, have been examined.  The results confirm the finding  (10) that the T15 
idiotype is  readily detectable  in  the  normal  serum  of only those  mice  which 
bear the a I allotype. When the PC-specific response of the B cells was analyzed 
in the splenic focus system, neither the number of PC-specific B  cells nor the 
frequency of B  cells which  express the  T15  clonotype within  that  population 
appeared to be related to allotypic markers. The strains tested could be divided 
into two groups with respect to the PC-specific precursor B-cell population. All 
strains bearing the BALB/c major histocompatibility complex (MHC) haplotype 
(H-2 d) displayed frequencies of anti-PC precursor B cells in the range of 15-20/ 
106 splenic B cells. In contrast, all strains bearing the C57BL/6 MHC haplotype 
(H-2 b) exhibited anti-PC precursor frequencies in the range of 2-4/106 splenic B 
cells.  The T15 clonotype was present at the precursor cell level in all strains, 
whether  a 1 or  a 2,  and  interstrain  T15  frequency  variations  correlated  with 
neither allotype nor MHC  haplotype.  Further,  monoclonal antibodies  from a 2 
individuals  could be  shown  to  be  indistinguishable  from T15  in  the  idiotype 
assay employed. 
These  findings  indicate  that  although  both  BALB/c  and  C57BL/6  mice 
express an equivalent clonotype at the precursor cell level and the frequency of 
these  precursors  is  independent  of allotype,  the  control  of serum  clonotype 
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Materials and Methods 
Mice.  All  mice  used  in these  studies  were  6-12  wk  of age.  BALB/c  and  A/He  mice were 
obtained from the Institute for Cancer Research, Philadelphia, Pa. Bailey CXB RI mice (19, 20) 
and  (BALB/c  x  C57BL/6)F1  mice  were  bred  in  our  animal  colony  from  stocks  originally 
obtained  from  The  Jackson  Laboratory,  Bar  Harbor,  Maine.  B10.D2  mice  were  purchased 
directly  from  The  Jackson  Laboratory,  and  CB2O  mice  (10)  were  obtained  from  Dr.  Michael 
Potter, National Cancer Institute, National Institutes of Health, Bethesda, Md. 
Antigens.  The preparation and characterization of PC-tyrosylglycyl-glycine  (TGG) and 2,4- 
dinitropbenyl  (DNP)  conjugates  of Limulus polyphemus  hemecyanin  (Hy)  and  bovine serum 
albumin (BSA) have been described in detail previously (16, 21, 22). 
Diplococcus pneumoniae,  strain R36A, obtained from Dr.  R. Austrian, University of Pennsyl- 
vania, Philadelphia, Pa., was heat-killed at 9O°C for 60 rain. 
Myeloma Proteins.  The BALB/c plasmaeytomas T15,  MOPC  167  (anti-PC),  and MOPC  460 
(anti-DNP) were obtained from Dr. Michael Potter at the National Cancer Institute. PC-binding 
myeloma  proteins  (23)  were  purified  from  ascitic  fluid obtained from  tumor-bearing mice  as 
previously  described  (16)  using  a  PC-Sepharose  column prepared  according to  the  method of 
Chesebro and Metzger (24). 
Immunizations.  (BALB/c ×  C57BL/6)F1 mice were immunized intraperitoneally with 0.1 mg 
of Hy in complete Freund's adjuvant 6-10 wk before use as recipients in cell transfer experiments. 
All mice used in serum antibody studies were exactly 6 wk of age. Mice were immunized to D. 
pneumoniae  by a single intraperitoneal injection of 5  x  108 heat-killed organisms, and they were 
individually bled from the supraorbital sinus both immediately before, and 1 wk after immuniza- 
tion. Sera were stored frozen until assayed for anti-PC antibodies and T15 idiotype. 
Anti-idiotype serum to T15 was prepared in A/He mice according to the protocol of Lieberman 
and Humphrey  (25),  and has been described in detail elsewhere (17).  The serum obtained was 
passed over an MOPC 460 protein-Sepharose column to remove anti-allotype activity, and it was 
subsequently employed in the radioimmunoassay for the T15 idiotype. 
Splenic Focus Technique.  Spleen-cell preparations from donor mice were prepared by teasing 
the cells from the spleen in Dulbecco's modified Eagle's medium. The cells were washed once and 
resuspended  in  cold  medium.  2-5  x  107  viable  cells  were  injected  intravenously  into  Hy- 
immunized recipients that had been irradiated with 1,300 rad from a cesium source 4-6 h earlier. 
Fragment cultures were prepared from recipient spleens 16-18 h  after cell transfer as described 
previously  (26).  The  fragments  were  stimulated  individually  with  PC-TGG-Hy  (1  x  10 -e  M 
hapten) or DNP-Hy,  and culture  fluids were  changed every 3 days.  Fluids collected 9-18 days 
after  stimulation  were  assayed  for  anti-hapten  antibodies  and  heavy-chain  isotypes.  Subse- 
quently, the supernates from fragments which produced PC-specific antibodies were assayed for 
the T15 idiotype. 
Radioimmunoassay  for Anti-Hapten  Antibodies.  The assay of culture fluids for specific anti- 
PC or anti-DNP antibodies by a  radioimmunoassay in which antigen (PC-BSA or DNP-BSA) is 
immobilized by adsorption to  wells of polyvinyl plates has been described in detail elsewhere 
(14).  Specific antibody was detected by purified, ~25I-labeled  goat anti-mouse-~, -T,  -~, or rabbit 
anti-mouse fragment antigen binding (Fab). 
Radioimmunoassay  for T15 ldiotype.  Idiotype  assays were  performed  by  a  modification of 
previously reported procedures  (15,  16).  Briefly, the dilution of anti-idiotypic antibodies where 
control binding and inhibition were optimal was  determined.  Then,  0.1  ml of the appropriate 
dilution was added to wells of polyvinyl plates and incubated for 6 h  at room temperature.  The 
anti-idiotype serum was withdrawn, the plates were then washed once with phosphate-buffered 
saline  (PBS),  0.2  ml  of PBS containing  1%  BSA  (PBS-BSA) was  added,  and the plates were 
incubated for 30  min  at  room  temperature.  The  PBS-BSA was  removed and the  plates  were 
washed  once  with  PBS.  Subsequently,  20  ~1  of various  concentrations of unlabeled standard 
inhibitor proteins, culture fluids, or serum dilutions were added, followed by 0.1 ml of PBS-BSA 
containing ~2  ng of ~25I-labeled  T15 protein with a  specific activity of 15-20  /~Ci/~g.  After an 
18 h  incubation at 37°C,  the plates were washed six times with PBS and counted in a  gamma 
counter. 
Iodination  of Myeloma Proteins and Antisera.  Purified goat anti-mouse-~, -T,  and -a sera; 
purified rabbit anti-mouse Fab sera; and purified T15 protein preparations were iodinatod by the D'FF'.RENT'AL ExPRzSS ON  OF  AN   QUIVAL',N   CLONOT FE 
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Fro. i.  Representative curves obtained from analysis of  normal and immune sera for  TI5 
reactivity. Individual mice were immunized with D. pneumoniae  and bled immediately 
before, and I  wk after  immunization. Doubling dilutions  of  the serum were made in PBS- 
BSA and each dilution  tested in triplicate  in the T15 radioimmunoassay  (see Materials 
and Methods),  ©, normal serum; A, immune serum. The coefficient  of variation for such 
determinations was between 4 and 7%.  Points are the means _+  SD. 
chloramine-T procedure with carrier-free  12~I  (Amersham/Searle  Corp.,  Arlington  Heights, Ill.) 
as described previously (21,  22). 
Results 
Quantitation of the T15 Idiotype in Normal and Immune Sera.  The results 
of an analysis of the T15 content of serum from normal and immune mice are 
shown in Fig.  1 and Table  I.  For each serum tested,  the maximum possible 
inhibition of control  125I-T15 binding  in the  idiotype assay was  determined. 
This  parameter  is  essential  for  a  critical  appraisal  of data  obtained  with 
heterogeneous antibody mixtures since  maximum inhibition values of >90% 
probably reflect the  presence  of antibodies identical to T15,  whereas  values 
which fall below this level may indicate either extremely small quantities of 
antibodies identical to T15,  or antibodies which only partially share determi- 
nants with T15. With this interpretive precaution in mind, the concentration of 
T15  or  T15-1ike  antibodies  present  in  the  serum  was  determined  from  the 
serum dilution at which 50% inhibition of control 125I-T15 binding was observed. 
This calculation, however,  is  based upon the  assumption that the reactivity 
present in the serum is identical to T15  and must therefore be considered in 
conjunction with the  maximum inhibition figures.  Sera  from mice of the  a 1 
allotype consistently inhibited  90%  or  more  of '25I binding  at  low  dilutions 
(Table  I),  and  generally contained  between  8  and  32  ~g/ml  of T15.  Upon 
immunization, these strains exhibited five- to sixfold increases in the serum 
levels of T15; sometimes reaching concentrations of >100 ~g/ml. Considerable 
variation in these levels was observed among mice of a  given strain. Normal MICHAEL  P.  CANCRO,  NOLAN  H.  SIGAL,  AND  NORMAN  R.  KLINMAN 
TABLE  I 
Analysis of Normal and Immune Sera for T15 Idiotype 




Serum* T15 concentration 
Mean  Range 
%  (~g/rnl) 
BALB/c  a ~  Before  89  17  8-32 
After  95  90  64-128 
CXBG  a I  Before  90  13  8-32 
After  90  90  64-128 
CXBJ  a I  Before  92  24  8-32 
After  90  83  32-128 
C57BL/6  a  2  Before  65  <2  - 
After  55  <2  - 
CXBD  a  2  Before  80  <2  <2-4 
After  93  14  8-30 
CXBE  a  2  Before  60  <2  - 
After  60  4  <2-8 
CXBH  a  2  Before  41  <2  - 
After  85  11  4-32 
CXBI  a  2  Before  47  <2  - 
After  60  <2  - 
CXBK  a  2  Before  60  <2  - 
After  55  <2  - 
CB20  a  s  Before  65  <2  - 
After  85  4  2-8 
* Serum concentration was calculated from the dilution  at which 50% inhibition  of  control 125I- 
T15 binding was observed. 
sera from mice of the a 2 allotype, however, never showed inhibition of I~I-T15 
binding comparable to that  observed with  sera from  mice of the  a 1 allotype. 
Upon  immunization,  however,  the  a2-bearing strains  displayed various  pat- 
terns.  C57BL/6,  CXBE,  CXBI, and CXBK strains showed little or no increase 
in  inhibitory capacity and  maintained either  extremely low  or  undetectable 
amounts  of serum  T15  based  upon  the  dilution  at  which  50%  inhibition of 
control  binding was  observed.  CB20,  CXBD,  and  CXBH  mice,  on  the  other 
hand, exhibited increases in inhibitory capacity to levels comparable to BALB/ 
c  individuals. In conjunction, these strains displayed detectable quantities of 
T15-1ike protein in their immune sera (Table I). 
Analysis of the Anti-PC Precursor Cell Frequency in RI Strains of BALB/c 
and  C57BL/6  Origin.  Previous  studies  have  shown  that  the  frequency  of 
primary anti-PC precursor B  cells in the BALB/c mouse is 1 per 50,000-100,000 
splenic B cells (15). In most other strains examined, the magnitude of the anti- 
PC specific precursor B-cell population is only slightly lower than that observed 
in  BALB/c  mice  (17).  Precursor  cell  frequency  analysis  of  C57BL/6  mice, 
however, indicated that the anti-PC precursor frequency was 5- to 10-fold lower 
than  in  BALB/c  individuals (Table  II).  It was  thus  of particular interest to 
examine the  RI  strains of these  parental types to  determine whether  or not 
high  and low frequency precursor characteristics segregated. Analysis of the 
Bailey CXB  RI strains (Table II) indicated that these strains could be divided DIFFERENTIAL  EXPRESSION  OF  AN  EQUIVALENT  CLONOTYPE 
TABLE  II 
Summary of T15- and PC-Specific Precursors in BALB/c, C57BL/6, 
Recombinant Inbred, and Congenic Strains 
Strain  H-2  Allotype 
T15-positive  PC-specific pre-  precursors per 
cursors per l0  s  106 splenic B 
splenic B cells*  cells 
BALB/c  d  a 1  16  10 
CB20  d  a 2  23  8 
B10.D2  d  a 2  11  1 
CXBD  d  a ~  15  2 
CXBH  d  a 2  16  7 
CXBE  b  a 2  2  0.6 
CXBG  b  a 1  2  0.7 
CXBI  b  a 2  3  0.6 
CXBJ  b  a ~  3  2 
CXBK  b  a s  4  0.6 
C57BL/6  b  a 2  2  1 
(BALB/c  ×  d/b  al/a  2  16  5 
C57BL/6)F1 
* Precursor frequencies  given are after correction  for homing efficiency of 
donor cells and cloning efficiency (14). 
into  two  categories with  respect to  the  magnitude  of their  anti-PC  precursor 
frequency.  CXBD  and  CXBH  strains  exhibited  a  high  frequency  of primary 
anti-PC  precursors,  similar to that of BALB/c.  The other RI strains,  however, 
displayed a  low frequency comparable to that of C57BL/6  mice. The two high 
frequency  strains  were  the  only  RI  lines  tested  which  possess  the  BALB/c 
MHC haplotype (H-2d), whereas all other RI lines examined carry the C57BL/6 
haplotype  (H-2b).  These  results  suggested  that  elements  which  govern  the 
frequency of anti-PC  precursor cells might be linked to the  MHC.  To further 
investigate  this  possibility,  the  anti-PC  response  of the  B10.D2  and  CB20 
congenic  strains  were  analyzed.  The data from such experiments  support the 
association of high  anti-PC  precursor frequency with H-2  d (Table II), as these 
mice display a  relatively high frequency of primary anti-PC  clones.  (C57BL/6 
×  BALB/c)F1  mice  also  show  a  high  frequency  of anti-PC  precursor  cells, 
suggesting that expression of high frequency is genetically dominant. 
To eliminate trivial explanations for the observed differences in the anti-PC 
precursor  frequency  based  upon  donor-recipient  interactions  of an  unknown 
nature,  representative  high and low frequency anti-PC  strains  were tested in 
the  same  experimental  system  for  the  anti-DNP  response.  Since  the  DNP 
response  displays similar  frequencies  among  all  murine  strains  examined, 
including  BALB/c and C57BL/6  (14,  and unpublished  observation), one would 
expect to obtain similar frequencies among the  RI strains  if the experimental 
system were examining only properties attributable to the donor B-cell popula- 
tion.  The  results  from such  experiments  support  this  assumption,  since  very 
similar  anti-DNP  precursor  cell  frequencies  were  obtained  in  each  of  the 
strains tested. 
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Strains  of BALB/c  and  C57BL/6  Origin.  The  anti-PC  response  in  BALB/c 
mice is dominated  by the  T15 clonotype  (16),  which comprises 40-80%  of the 
BALB/c primary anti-PC  repertoire.  The presence of a  predominant  clonotype 
in  the  PC  response  is  apparently  unique  to  the  BALB/c strain,  since  other 
strains examined do not appear to express one clonotype in such predominance 
(17).  In the present experiments,  the analysis of the T15 clonotype frequency 
has been extended to B10.D2 and CB20 congenic mice as well as the RI strains 
of BALB/c and C57BL/6 origin.  Monoclonal antibodies which were obtained in 
the previously described experiments were tested using mouse anti-T15 serum 
in the competitive binding radioimmunoassay.  The results of this analysis are 
shown in Table II,  and  reveal that  the T15 clonotype is present  in  all tested 
strains,  although at different frequencies. Furthermore,  the relative frequency 
of the  T15  clonotype  in  a  given  strain  is  associated  with  neither  the  MHC 
haplotype nor the Ig allotype of that strain. 
Characterization  of T15-Positive  Monoclonal  Antibodies  from  a 2 Allotype 
Individuals.  Since the results demonstrate that the expression of T15 at the 
level of the individual precursor B cell is not allotype-linked, it was important 
to  determine  whether  or  not  the  monoclonal  antibodies  designated  as  T15- 
positive were in fact identical to the prototype T15 protein within the limits of 
the  assay  system.  More  specifically,  we  wished  to  find  to  what  extent  the 
results reflected partially shared determinants.  Therefore, representative mon- 
oclonal antibodies,  which had been designated T15-positive,  were chosen and 
serial  dilutions  of these were examined  in both the T15 and  Fab radioimmu- 
noassays.  The  results  were  compared  to  those  obtained  with  purified  T15 
protein standards. The results (Fig. 2) indicate that even at high concentrations, 
the  experimentally  obtained  monoclonal  antibodies  were  indistinguishable 
from T15 by the antisera  employed, and that the monoclonal antibodies could 
inhibit as much as 90% of the binding of the iodinated T15 to the anti-idiotypic 
serum. 
Discussion 
We have examined the frequency and clonal composition of the primary anti- 
PC  B-cell  pool  in  C57BL/6,  BALB/c,  RI,  and  congenic  strains  derived  from 
these  parental  types.  The  results  of these  studies  and  a  detailed  analysis  of 
serum  antibodies  provide  evidence  which  suggests  that  a  complex  set  of 
regulatory phenomena influence precursor cell and serum antibody expression. 
The frequency of PC-specific B  cells in  C57BL/6 mice is 5- to  10-fold lower 
than that observed in BALB/c mice. Moreover, anti-PC precursor cell frequency 
analysis of RI and  congenic lines  of BALB/c and  C57BL/6 origin  reveal that 
this  characteristic  follows the MHC in the strains  examined.  CXBH,  CXBD, 
B10.D2,  and  CB20 strains  (all H-2 ~) exhibit  a  high  PC precursor  frequency, 
whereas all H-2 b strains  examined  show a  low precursor frequency.  Whether 
or  not  this  represents  an  actual  linkage  of regulatory  elements  to  the  H-2 
complex, and whether or not the linkage can be attributed to subregions within 
the H-2 complex will require additional experiments with the appropriate con- 
genic strains. 
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Fro.  2.  Comparison of monoclonal  antibody designated T15-positive  and T15  myeloma 
protein in the T15  and Fab radioimmunoassays.  Monoclonal antibody from mice of the 
a s allotype was serally diluted with PBS-BSA and tested in beth the T15 and PC radio- 
immunoassays.  Purified T15 at standard concentrations was tested in the same fashion. 
The  points  shown are  means of at  least  four replicates.  The coefficient of variation in 
the Fab assay  was between 7  and 12%.  Error bars show the SD of the cpm in the T15 
assay.  ©, T15 protein; A, monoclonal antibody 772 from CXBH mouse. MOPC 167 protein 
at  a  20-~g  concentration  (B)  was  included to  demonstrate  the  specificity  of the  assay 
system. 
idiotype  among the  RI  strains  reveals  that  B  cells  which  express  the  T15 
clonotype are present in all strains examined, whether they are of the a 1 or a 2 
allotype. Recently, Gearhart and Cebra (27) have also reported the presence of 
T15  precursors  in  CB20  and  B10.D2  congenic strains,  and they have  shown 
that the IgA antibodies of this idiotype do not bear the a 1 allotype. Although 
the data presented here do not prove identity of the variable regions derived 
from the different strains,  monoclonal antibodies from either a 1 or a  2 donors 
were not distinguishable from the T15 myeloma protein by the idiotype assay 
employed at either high or low concentrations. 
Claflin and Davie  (28) have described a  combining site-associated idiotypic 
determinant on T15  which is detected by rabbit anti-T15 serum and which is 
found in immune sera of all murine strains tested. The anti-idiotypic serum 
used in this study and that used by Lieberman et al. (10), however, were raised 
in A/He mice, and since their binding is not appreciably inhibited by hapten, 
they probably detect variable region determinants outside the antibody-combin- 
ing  site.  Thus,  the  presence  of the  T15  idiotype as  analyzed in  this  report 
indicates  identity  with  the  T15  protein  in  the  framework  portions  of the 
variable region, rather than a  conserved combining-site determinant present 
in  varying frameworks.  It  should  be  noted  that  representative  monoclonal 
antibodies derived from either a ~ or a 2 mice and designated in this report as 
T15-positive  by allogenic antiserum analysis were  also  indistinguishable by 
analysis with rabbit anti-T15 serum. 
Thus,  the  expression  of a ~ or  a 2 allotype does  not dictate the presence  or MICHAEL  P.  CANCRO,  NOLAN  H.  SIGAL,  AND  NORMAN  R.  KLINMAN  9 
absence of the structural VH gene for T15,  and appears to have little influence 
upon the frequency of T15 precursors within the B-cell repertoire. For example, 
BALB/c and CXBJ mice, both of the a 1 allotype, display high frequencies of the 
T15 clonotype, whereas CXBD mice, which are also a 1, show a  comparatively 
low frequency of the T15 clonotype. Similarly, examples of both high and low 
T15 frequencies are observed among the strains bearing the a 2 allotype. 
Previous  reports  (e.g.  10)  have  demonstrated that  high  levels  of the  T15 
idiotype in normal or immune serum are closely associated with the presence 
of the a ~ allotype, and results in this report confirm this finding. One possible 
source of the apparent  discrepancy between serum expression and precursor 
frequency  might  be  that  the  mouse  anti-T15  serum  was  directed  against 
several determinants, all of which are present on the T15 molecule, and only 
some of which are present on the C57BL/6 anti-PC molecules which we have 
designated as T15-positive.  This is probably not the case,  however,  since we 
have employed the criterion of a  1:1 weight relationship between the Fab and 
idiotype determinations of a  particular monoclonal antibody in order for it be 
designated as  T15-positive.  Further,  we  have  shown that  similar inhibition 
curves may be obtained with either purified T15 protein or monoclonal antibod- 
ies designated as T15-positive, and these curves approach complete inhibition 
of 1~5I-T15 binding.  It  would be  premature,  however,  to  postulate  complete 
identity between the  monoclonal antibodies examined in this study and the 
T15 protein, since serological techniques may be insensitive to subtle differences 
which might be elucidated by amino acid sequence studies. It is more difficult 
to firmly establish close identity of antibodies in heterogeneous serum mixtures 
with the T15  protein.  This factor is illustrated by the data presented herein 
with respect to serum levels of the T15  idiotype. Since complete inhibition of 
the  ~25I-T15 binding in the  idiotype assay was observed only with sera from 
mice of the a 1 allotype, the lesser inhibition observed with serum from mice of 
a 2 allotype might be  the  result of cross-reactive antibody populations which 
share  some T15  determinants. On the other hand,  since it is  clear from the 
analysis of monoclonal antibodies that all  strains  examined possess  the T15 
clonotype at the precursor level, it is equally possible that mice which bear the 
a 2 allotype express T15 in their sera, but at levels too low to produce complete 
inhibition. If this is the case, it would appear that C57BL/6 mice fail to use this 
clonotype in their response to R36A, whereas CB20 and CXBH mice do so to a 
limited extent.  This result parallels the data of Lieberman et al.  (10), who 
observed that the hemagglutination inhibition titers of T15 in the sera of CB20 
and CXBH mice increased slightly upon immunization, whereas that of C57BL/ 
6 mice did not. 
Two critical points emerge from the findings reported here: (a) the allotype 
of an  individual,  although closely related to  serum levels of an  idiotype,  is 
unrelated to the proportion of the precursor population which expresses that 
idiotype; and (b) the serum expression of a given idiotype may reflect regulatory 
processes more than the actual clonotype representation in the B-cell repertoire. 
It is apparent from these findings that a  distinction must be made between 
the  expression of idiotypic determinants within precursor  B-cell populations 
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serum antibodies. This distinction places limitations upon the inferences which 
may be drawn from either the examination of in vivo serum antibody or the 
study of precursor B-cell populations in vitro. Foremost among these limitations 
is  the extent to which such data  may be  used to  assess  the structural gene 
complement  of an  individual  or  a  strain.  Thus,  the  examination of serum 
antibody  may  be  misleading  if it  is  assumed  to  be  representative  of the 
complete VH gene repertoire.  Analysis of precursor B-cell populations stimu- 
lated in vitro, on the other hand, overcomes many ambiguities inherent in the 
examination of serum antibodies and thus allows a more thorough assessment 
of the structural gene complement of an individual. However,  such analyses 
cannot necessarily be used for the accurate prediction of the antibodies which 
will be elicited during an in vivo immune response. It is imperative, therefore, 
that results obtained from each system be  interpreted within the context of 
these limitations. 
One  distinction between the regulation of precursor population magnitude 
and the  allotype-associated regulation of serum  antibody levels may be that 
the latter appears to be antigen-driven whereas the former is not. For example, 
previous  reports  from  this  laboratory  have  shown  that  the  T15  precursor 
population  in  germ-free  mice  is  similar  to  that  observed  in  conventionally 
reared mice. In contrast, germ-free BALB/c mice do not express T15  in their 
sera,  but  they  may  be  induced  to  do  so  upon  exposure  to  a  conventional 
environment (10). This  distinction would suggest that the development of B 
cells  which  express  various  VH  determinants  is  relatively  independent  of 
external influences, but the capacity of these cells to proliferate and secrete 
antibodies will be dictated by other regulatory mechanisms. 
The  observed dichotomy between serum  expression  and precursor cell fre- 
quency also places constraints upon the designation of a  given clonotype as a 
germline antibody specificity. Although the T15 clonotype is considered to be 
encoded in the germline because of  its high frequency in all BALB/c individuals, 
it is present at low frequency in some RI strains.  Moreover, CB20  and CXBH 
mice possess populations of T15 precursor cells whose magnitude is not directly 
reflected  in  either  normal or  immune sera.  Clonotypes present  at  very low 
frequency have been described in other systems (13), but have generally been 
interpreted  as  a  reflection  of somatically generated  specificities,  since  one 
criterion for a germline specificity has been its presence in all individuals of a 
particular strain. Since the T15 clonotype is generally accepted as a  germline 
specificity, the  present  observations  suggest  that  at  least  some  minor  (low 
frequency)  clonotypes  are  encoded  by  germline  information,  and  that  the 
distinction between major and minor clonotypes at the serum antibody level 
might reflect differences in genetic background,  rather than  VH  gene differ- 
ences. It will now be of  importance to examine these possibilities in detail and to 
determine whether or not other idiotypic systems display the same dichotomy 
between  specificities which  are  expressed  within precursor  populations  and 
those which are observed in serum antibodies. 
Summary 
The primary anti-phosphorylcholine (PC) response in BALB/c, C57BL/6, and 
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examined in the splenic focus system. The frequencies of PC-specific precursors 
were shown to vary among these strains from 2 to 20 precursors per 106 splenic 
B  cells.  The distribution of these frequencies suggests  that  elements closely 
linked to or within the major histocompatibility complex may play a role in the 
determination of  this parameter, although additional experiments are necessary 
to adequately assess this possibility. Moreover, all strains tested, regardless of 
immunoglobulin allotype,  expressed monoclonal antibodies  indistinguishable 
from the TEPC 15 myeloma protein (T15) clonotype. Further, the frequency of 
this clonotype in a  given strain did not appear related to allotype, since both 
high and low T15 frequencies were found among strains of either the BALB/c 
(a  1)  or C57BL/6  (a  ~)  allotype.  The examination of normal  serum for the T15 
idiotype, however, revealed that only mice of  the BALB/c allotype (a  ~) expressed 
the T15 idiotype in detectable quantities. After immunization with Diplococcus 
pneumoniae,  sera  from  mice  of the  a 1 allotype consistently contained  large 
quantities  of the  T15  idiotype,  whereas  sera  from  mice  of the  a 2 allotype 
exhibited various degrees of cross-reactivity with anti-T15 antibody. 
These results suggest that: (a) the allotype of an individual, although closely 
related to serum  levels of an  idiotype, is  unrelated to the  proportion of the 
precursor population which expresses that idiotype and;  (b) the serum expres- 
sion  of a  given  idiotype  may  reflect regulatory processes,  which  act  either 
during  or  before  antigenic  stimulation,  rather  than  the  actual  clonotype 
representation in the repertoire. These findings indicate that distinctions must 
be made between the expression of idiotypic determinants within precursor B- 
cell  populations and  elements which  regulate the  subsequent  appearance of 
those idiotypes in serum antibodies. 
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acknowledged. 
Received  for publication 19 August 1977. 
References 
1.  Blomberg, G., W. Geckeler, and M. Weigert.  1972. Genetics of  the antibody response 
to dextran in mice. Science  (Wash. D. C.).  177:178. 
2.  Riblet,  R., M.  Cohn, and M. Weigert.  1975. Analysis of the dextran response gene. 
Immunogenetics. 2:525. 
3.  Pawlak,  L.  L.,  and  A.  Nisonoff.  1973. Distribution of a  cross-reactive idiotypic 
specificity in inbred strains of mice. J. Exp. Med. 137:855. 
4.  Pawlak, L. L., E. B. Mushinski, A. Nisonoff, and M. Potter. 1973. Evidence for the 
linkage of the IgCH locus to a  gene controlling the idiotypic  specificity  of anti-p° 
azophenylarsonate antibodies in strain A mice. J. Exp. Med. 137:22. 
5.  Eichmann,  K.  1972. Idiotype expression and  the  inheritance of mouse  antibody 
clones. J. Exp. Med. 137:603. 
6.  Berek, C., B. A. Taylor, and K. Eichmann. 1976. Genetics of the idiotype of BALB/c 
myeloma Sl17: multiple chromosomal loci for VH genes encoding specificity for group 
A streptococcal carbohydrate. J. Exp. Med. 144:1164. 
7.  M~ikel~i,  O., and T. Iminashi. 1975. Expression of  an IgVH gene in natural antihapten 
antibodies.  Eur. J. Immunol. 5:202. 
8.  Imanishi, T., and M~ikel~i, O.  1975. Inheritance of antibody specificity.  II. Anti-(4- 
hydroxy-5-bromo-3-nitrophenyl)  acetyl in the mouse. J. Exp. Med. 141:840. 12  DIFFERENTIAL  EXPRESSION  OF  AN  EQUIVALENT  CLONOTYPE 
9.  Fathman,  C.  G.,  D.  S.  Pisetsky,  and  D.  H.  Sachs.  1977. Genetic  control  of the 
immune response to nuclease.  V.  Genetic linkage and strain  distribution  of anti- 
nuclease idiotypes. J. Exp. Med.  145:569. 
10.  Lieberman, R.,  M.  Potter,  E.  B.  Mushinski,  W.  Humphrey, Jr.,  and S.  Rudikoff. 
1974. Genetics of a new IgV~ (T15 idiotype) marker in the mouse regulating natural 
antibody to phosphorylcholine. J. Exp. Med.  139:983. 
11.  Claflin, J. L., R. Lieberman, and J. M. Davie. 1974. Clonal nature of the immune 
response to phosphorylcholine. II. Idiotypic specificity and binding characteristics of 
anti-phosphorylcholine antibodies. J. Immunol. 112:1747. 
12.  Eichmann, K. 1975. Genetic control of antibody specificity in the mouse. Immunoge- 
netics.  2:491. 
13.  Nisonoff, A., S-T. Ju, and F. L. Owen. 1977. Studies of structure and immunosuppres- 
sion of a cross-reactive idiotype in strain A mice. Transplant. Rev. 34:89. 
14.  Klinman, N. R., A. R. Pickard, N. H. Sigal, P. J. Gearhart, E. S. Metcalf, and S. K. 
Pierce.  1976. Assessing B cell diversification by antigen receptor and precursor cell 
analysis. Ann. Immunol.  (Paris).  127C:489. 
15.  Sigal, N., P. Gearhart, and N. Klinman. 1975. The frequency of phosphorylcholine- 
specific B-cells in conventional and germfree mice. J. Immunol. 68:1354. 
16.  Gearhart, P. J., N. H. Sigal, and N. R. Klinman. 1975. Heterogeneity of the BALB! 
c antiphosphorylcholine antibody response at the precursor cell level. J. Exp. Med. 
141:56. 
17.  Gearhart,  P.  J.,  N.  H.  Sigal,  and  N.  R.  Klinman.  1977. The  monoclonal  anti- 
phosphorylcholine antibody response in several murine strains: genetic implications 
of a diverse repertoire. J. Exp. Med. 145:876. 
18.  Sigal, N. H., P. J. Gearhart, J. L. Press, and N. R. Klinman. 1976. Late acquisition 
of a germline specificity. Nature (Lond.). 259:51. 
19.  Bailey, D. W. 1971. Recombinant inbred strains. An aid to finding identity, linkage, 
and function of histocempatibility and other genes. Transplantation  (Baltimore).  11: 
1325. 
20.  Bailey, D. W. 1975. Genetics of histocompatibility in mice. I. New loci and congenic 
lines. Immunogenetics. 2:249. 
21.  Klinman,  N.  R.  1972. The  mechanism  of antigenic  stimulation  of primary and 
secondary clonal precursor cells. J. Exp. Med. 136:241. 
22.  Klinman, N. R., and G. Aschinazi.  1971. The stimulation of splenic foci in vitro. J. 
Immunol. 106:1338. 
23.  Leon,  M.  A.,  and  N.  M.  Young.  1971. Specificity  for  phosphorylcholine  of six 
myeloma proteins reactive with pneumonococcus C polysaccharide and fl-lipoprotein. 
Biochemistry.  10:1424. 
24.  Chesebro, B., and H. Metzger. 1972. Affinity labeling ofa phosphorylcholine binding 
mouse myeloma protein. Biochemistry.  11:766. 
26.  Lieberman, R., and W.  Humphrey. 1971. Association of H-2 types with the genetic 
control of immune responsiveness to IgA allotypes in the mouse. Proc. Natl. Acad. 
Sci.  U. S. A. 68:2510. 
26.  Press, J.,  and N. Klinman.  1974. Frequency of hapten specific B cells in neonatal 
and adult murine spleens. Eur. J. Immunol. 4:155. 
27.  Gearhart,  P.  J.,  and J.  J.  Cebra.  1977. Presence  of the  T15  clonotype in  mouse 
strains differing in IgCu allotype. Immunogenetics. In press. (Abstr.). 
28.  Claflin,  J.  L.,  and J.  M.  Davie.  1974. Clonal  nature  of the  immune response to 
phosphorylcholine.  IV.  Idiotypic  uniformity  of binding  site-associated  antigenic 
determinants among mouse anti-phosphorylcholine antibodies. J. Exp. Med. 140:673. 